Although there is a growing interest in the role of NK cells in oncohematologic disorders [13–17], to the best of our knowledge, there is only one previous report investigating the possible involvement of KIR genes in cHL [18]. This evidence concerns the gene KIR3DL1 and classic Hodgkin lymphoma.